Core Viewpoint - A class action securities lawsuit has been filed against AppLovin Corporation, alleging securities fraud that affected investors between May 10, 2023, and March 26, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that AppLovin's management provided misleading information regarding the company's financial growth and stability, particularly related to the launch of its AXON 2.0 digital ad platform and the use of advanced AI technologies [2]. - Allegations include that AppLovin engaged in dishonest advertising practices, such as reverse engineering advertising data from Meta Platforms and manipulating ad metrics to inflate performance figures [2]. - Following the revelation of these practices on February 26, 2025, AppLovin's stock price dropped from $377.06 to $331.00 per share, reflecting a significant loss for investors [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until May 5, 2025, to request appointment as lead plaintiff in the lawsuit [3]. - Participation in the lawsuit does not require any out-of-pocket costs for class members, as compensation may be available without financial obligation [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4]. - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].

Core Viewpoint - Halper Sadeh LLC is investigating potential violations of federal securities laws and breaches of fiduciary duties related to the mergers of Coeptis Therapeutics Holdings, Inc. and Pacific Premier Bancorp, Inc. [1][2] Group 1: Coeptis Therapeutics Holdings, Inc. - The investigation focuses on Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) regarding its merger with Z Squared Inc. [1] - Shareholders of Coeptis are encouraged to learn about their legal rights and options related to the merger [1] Group 2: Pacific Premier Bancorp, Inc. - Pacific Premier Bancorp, Inc. (NASDAQ: PPBI) is being investigated in connection with its sale to Columbia Banking System, Inc. [2] - The sale involves an exchange ratio of 0.9150 of a share of Columbia common stock for each Pacific share [2] - Shareholders of Pacific are urged to understand their rights and options concerning the transaction [2] Group 3: Legal Representation and Actions - Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures, and other relief on behalf of shareholders [3] - The firm operates on a contingent fee basis, meaning shareholders would not incur out-of-pocket legal fees or expenses [3] - Shareholders can contact the firm for free consultations regarding their legal rights and options [4]

Core Viewpoint - A lawsuit has been filed against The Bancorp, Inc. and its senior executives for potential violations of federal securities laws, alleging misrepresentation of risks associated with its loan portfolio [1][2][4]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the District of Delaware, captioned Linden v. The Bancorp, Inc., et al., No. 25-cv-00326, with investors having until May 16, 2025, to seek lead plaintiff status [2]. - The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Bancorp stock [2]. Group 2: Company Overview - Bancorp is a financial holding company involved in institutional banking, commercial real estate bridge lending, small business lending, and commercial fleet leasing, with its REBL loans primarily collateralized by apartment buildings [3]. Group 3: Allegations of Misrepresentation - The complaint alleges that Bancorp misrepresented the significant risk of default or loss on its REBL loan portfolio and that its credit loss methodology was inadequate [4]. - It is claimed that Bancorp misrepresented the effectiveness of its internal controls over financial reporting, which contained at least one material weakness [4]. Group 4: Stock Performance and Impact - Following a report from Culper Research on March 21, 2024, which highlighted misrepresentations regarding the risks of default on REBL loans, Bancorp's stock price fell over 10%, from $36.04 to $32.12 [5]. - On October 24, 2024, Bancorp reported a net income of $51.5 million, leading to a 14% decline in stock price from $54.96 to $47.01 due to increased credit losses [6]. - On March 4, 2025, Bancorp disclosed inappropriate filings of its Annual Report, causing a 4.4% drop in stock price from $53.59 to $51.25 [7].

Core Viewpoint - A lawsuit has been filed against Fluence Energy, Inc. and its senior executives for potential violations of federal securities laws, alleging misrepresentation of the company's competitive position and financial performance [1][2][4]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Eastern District of Virginia, titled Abramov v. Fluence Energy, Inc., et al., No. 25-cv-00444 [2]. - Investors have until May 12, 2025, to request to be appointed to lead the case [2]. Group 2: Allegations Against Fluence Energy - Fluence Energy is accused of misrepresenting its sales pipeline and backlog of orders, concealing declines in sales and earnings growth through aggressive revenue pull-forwards and selective earnings adjustments [4]. - A report by Blue Orca Capital revealed that Siemens Energy, a major revenue source for Fluence, filed a lawsuit against the company for misrepresentations and fraud [5]. Group 3: Financial Performance - In Q1 2025, Fluence Energy reported a net loss of $57 million, or $0.32 per share, with revenues falling 49% year-over-year [6]. - Following the financial results announcement, Fluence Energy's stock price dropped 46%, closing at $7.00 per share on February 11, 2025 [6].

Core Viewpoint - A lawsuit has been filed against Ready Capital Corporation and its senior executives for potential violations of federal securities laws, focusing on misrepresentation of the company's financial health due to non-performing loans in its commercial real estate portfolio [1][2][4]. Group 1: Lawsuit Details - The lawsuit is filed by Bleichmar Fonti & Auld LLP on behalf of investors who purchased Ready Capital stock, asserting claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [2]. - Investors have until May 5, 2025, to request to be appointed to lead the case, which is pending in the U.S. District Court for the Southern District of New York [2]. Group 2: Company Background - Ready Capital is a real estate finance company that originates, acquires, finances, and services lower-to-middle-market commercial real estate loans, small business administration loans, and other real estate-related investments [3]. Group 3: Financial Misrepresentation - The lawsuit alleges that the defendants misrepresented the impact of significant non-performing loans on the company's financial performance, which were not accurately reflected in its current expected credit loss (CECL) or valuation allowances [4]. - The financial results were claimed to be materially false and misleading due to the misrepresentation of these non-performing loans [4]. Group 4: Stock Performance - Following the announcement of financial results for Q4 2024, Ready Capital recognized a $382 million charge, including $284 million related to non-performing loans, and reduced its dividend to $0.125 per share [5]. - This announcement led to a nearly 27% decline in the stock price, dropping from $6.93 per share on February 28, 2025, to $5.07 per share on March 3, 2025 [6].

SAN DIEGO, April 30, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP notifies investors that it has commenced an investigation into whether Manhattan Associates, Inc. (NASDAQ: MANH) complied with the federal securities laws and state law regarding fiduciary duties owed to the Company and its shareholders. Did you purchase Manhattan Associates securities? If you purchased securities and suffered losses on your investment, or if you are a long time continuous holder of Manhattan Associates stock, join our inves ...

NEW YORK, April 30, 2025 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of NAPCO Security Technologies, Inc. (NASDAQ: NSSC) between February 5, 2024 and February 3, 2025, both dates inclusive (the "Class Period"). If you wish to serve as lead plaintiff, you must move the Court no later than June 24, 2025.So what: If you purchased NAPCO securities during the Class Period you may be entitled to compens ...

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices involving Amerant Bancorp Inc. and its officers or directors, following disappointing financial results for Q1 2025 that led to a significant drop in stock price [1][3]. Financial Performance - Amerant Bancorp reported GAAP earnings per share of $0.28 for Q1 2025, which was $0.12 below consensus estimates [3]. - The company's loans remained relatively flat quarter over quarter due to increased payoffs and paydowns offsetting new production [3]. - Following the earnings announcement, Amerant's stock price decreased by $2.55, or 13.09%, closing at $16.93 per share on April 24, 2025 [3].

Core Viewpoint - Landstar System, Inc. is under investigation for potential securities fraud and unlawful business practices following the disclosure of significant supply chain fraud that may impact its earnings [1][3]. Group 1: Company Disclosures - On April 2, 2025, Landstar identified a significant supply chain fraud that could adversely affect its first quarter 2025 earnings per share by $0.35 to $0.50, leading to the withdrawal of its previous earnings guidance [3]. - Following this announcement, Landstar's stock price dropped by $13.30, or 8.75%, closing at $138.63 on April 3, 2025 [3]. - On April 25, 2025, Landstar announced it would be unable to file its quarterly report on time due to ongoing evaluations of accounting and internal control matters related to the identified fraud [4]. - This news resulted in a further decline in Landstar's stock price by $4.92, or 3.52%, closing at $135.00 on April 25, 2025 [4]. Group 2: Legal Investigation - Pomerantz LLP is investigating claims on behalf of Landstar investors regarding potential securities fraud and unlawful business practices by the company and its officers or directors [1].

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices involving FTI Consulting, Inc. and its officers or directors [1] Financial Performance - FTI Consulting reported first-quarter 2025 revenue of $898.3 million, a year-over-year decline of 3.3%, missing consensus estimates by $8.38 million [3] - The company reported net income of $61.8 million, down from $80 million in the same period last year, attributed to lower revenues and a $25.3 million special charge related to severance and employee-related costs [3] - Following the financial results announcement, FTI's stock price decreased by $6.60 per share, or 3.92%, closing at $161.91 per share on April 24, 2025 [3]